Seller: Majestic Books, Hounslow, United Kingdom
US$ 73.41
Convert currencyQuantity: 3 available
Add to basketCondition: New.
Published by Taylor & Francis Ltd, 2021
ISBN 10: 1032098201 ISBN 13: 9781032098203
Language: English
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
US$ 82.35
Convert currencyQuantity: 1 available
Add to basketPaperback / softback. Condition: New. New copy - Usually dispatched within 4 working days. 185.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Seller: Biblios, Frankfurt am main, HESSE, Germany
US$ 91.08
Convert currencyQuantity: 3 available
Add to basketCondition: New.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 104.07
Convert currencyQuantity: 1 available
Add to basketPaperback. Condition: Brand New. 315 pages. 9.21x6.14x0.63 inches. In Stock.
Seller: Chiron Media, Wallingford, United Kingdom
US$ 183.63
Convert currencyQuantity: 5 available
Add to basketCondition: New.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
US$ 220.36
Convert currencyQuantity: Over 20 available
Add to basketCondition: New.
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 252.68
Convert currencyQuantity: 3 available
Add to basketCondition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 264.94
Convert currencyQuantity: Over 20 available
Add to basketCondition: New. In.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 275.46
Convert currencyQuantity: 3 available
Add to basketCondition: As New. Unread book in perfect condition.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 337.19
Convert currencyQuantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 297 pages. 8.00x5.00x1.00 inches. In Stock.
Seller: AHA-BUCH GmbH, Einbeck, Germany
US$ 328.34
Convert currencyQuantity: 1 available
Add to basketBuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, contributing to rising healthcare costs. Developability of Biotherapeutics: Computational Approaches describes applications of computational and molecular modeling techniques that improve the overall process of discovery and development by removing empiricism.The concept of developability involves making rational choices at the pre-clinical stages of biopharmaceutical drug development that could positively impact clinical outcomes. The book also addresses a general lack of awareness of the many different contributions that computation can make to biopharmaceutical drug development.This informative and practical reference is a valuable resource for professionals engaged in industrial research and development, scientists working with regulatory agencies, and pharmacy, medicine, and life science students and educators. It focuses primarily on the developability of monoclonal antibody candidates, but the principles described can also be extended to other modalities such as recombinant proteins, fusion proteins, antibody drug conjugates and vaccines.The book is organized into two sections. The first discusses principles and applications of computational approaches toward discovering and developing biopharmaceutical drugs. The second presents best practices in developability assessments of early-stage biopharmaceutical drug candidates.In addition to raising awareness of the promise of computational research, this book also discusses solutions required to improve the success rate of translating biologic drug candidates into products available in the clinic. As such, it is a rich source of information on current principles and practices as well as a starting point for finding innovative applications of computation towards biopharmaceutical drug development.